Bladder Cancer - Results from #120

Survival of Metastatic Urothelial Carcinoma of Urinary Bladder According to Number and Location of Visceral Metastases. July 22, 2024

Trends and Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers. July 22, 2024

Adjuvant immune checkpoint inhibitors for urothelial carcinoma: systematic review and Meta-analysis. July 22, 2024

Efficacy of Cretostimogene Grenadenorepvec and Pembrolizumab in BCG-Resistant NMIBC - Expert Commentary July 19, 2024

The current role of pentafecta in the reporting of radical cystectomy outcomes: a scoping review. July 19, 2024

Effect of Bacille Calmette-Guérin for Non-Muscle-Invasive Bladder Cancer After Prostate Radiotherapy. July 19, 2024

What is a Bladder Cancer Molecular Subtype? - Counterpoint. July 19, 2024

IMFINZI® (Durvalumab) Demonstrated Statistically Significant and Clinically Meaningful Improvement in Event-Free Survival and Overall Survival for Muscle-Invasive Bladder Cancer in NIAGARA Phase III Trial July 18, 2024

Comparison of Robotic vs Open Cystectomy: A Systematic Review. July 18, 2024

Advancing Clinical Trial Design for Non-Muscle Invasive Bladder Cancer. July 18, 2024

The Impact of Dose Reduction of Bacillus Calmette-Guerin on Oncological Outcomes and Toxicity in Non-Muscle Invasive Bladder Cancer: A Systematic Review and Meta-Analysis. July 18, 2024

Association of Tumor-informed Circulating Tumor DNA Detectability Before and After Radical Cystectomy with Disease-free Survival in Patients with Bladder Cancer. July 18, 2024

Predictive Value of Computed Tomography Following Neoadjuvant Chemotherapy for Muscle Invasive Bladder Cancer. July 17, 2024

NK Cell-Targeted Immunotherapies in Bladder Cancer: Beyond Checkpoint Inhibitors. July 17, 2024

Electromotive Drug Administration Chemotherapy with Mitomycin C Versus Bacillus Calmette-Guerin for the Treatment of Non-Muscle Invasive Bladder Cancer. July 17, 2024

Photocure and Richard Wolf Enter into Agreement to Develop a High-Definition Flexible Blue Light Cystoscope for Global Commercialization July 16, 2024

Bladder Cancer Advocacy Network (BCAN) Announces $600,000 in Funding to Propel Breakthroughs in Bladder Cancer Research July 16, 2024

Association of Histone H3 Trimethylation in Circulating Monocytes with Lack of Early Recurrence in Patients with Bladder Cancer following BCG Induction Therapy. July 16, 2024

Hypofractionated Radiation Therapy (Hypo-RT) for the Treatment of Localized Bladder Cancer. July 16, 2024

PARP Inhibitors for Metastatic Urothelial Carcinoma: A Systematic Review of Efficacy and Safety. July 15, 2024

Page 7 of 512